VIEW the workshops and conference schedule from this link2019 ANSA
Annual Conference & Workshops: Gateway to HealthThe Applied
Neuroscience Society of Australasia is a membership organization
comprised of health professionals from Australia, Australasia and New
Zealand who are involved in the promotion of better mental health.
ANSA promotes education and professional excellence in the fields of
Applied Psychophysiology, Neurotherapy and Nutrition seeking to
strengthen acceptance of these disciplines as viable avenues for
intervention to promote self-regulation in mental health and
well-being. ANSA members and other professionals interested in applied
neuroscience, are cordially invited to participate our annual
workshops and conference to be held in Cairns, gateway to the Great
Barrier Reef. Announcing presenters:Michelle Aniftos, Martijn
Arns, Mirjana Askovic, Trevor Brown, Dave Cantor, George
Carlson, Dirk de Ridder, Nick Dogris, Georgina Hale, Peggy
Hill, Herbert Jelinek, Martha Mack, Paula Rodrigues, Laura Rosas
Leong, Rivi Sela, Dave Siever, Ron Swatzyna, Tiff
Thompson, Adrian van Deusen, Steven Wickens, and more...FULL
PROGRAM available for download here.Pre-conference Workshops:Thursday
22/08/19> Mental Health Neurobiomarkers: discovering
neurological/physiological causes for symptoms is key for successful
treatmentFriday 23/08/19> Pharmaco-EEG & NeuromodulationDr. Ronald J.
Swatzyna is the Director of Electro-Neurophysiology Research and
Director of Neurotherapy at the Tarnow Center in Houston, Texas. For
the past 20 years, Dr. Swatzyna has analyzed and treated the most
diagnostically challenging cases in both inpatient and outpatient
settings. As a researcher, he has presented and/or published over 60
peer-reviewed papers on brain dysfunction, psychotropic medication and
other related topics at national and international conferences. In
addition, Dr. Swatzyna is a Special Editor for WebmedCentral and
Clinical EEG and Neuroscience. Prior to his career in mental health,
Dr. Swatzyna served in both the Vietnam and the first Gulf War. His
personal battle, with traumatic brain injury and PTSD, motivated him
to become a leading expert in brain dysfunction.Thursday &
Friday 22-23/08/19> Physiology and Clinical Outcomes with Brain
Stimulation Technologies: Audio-visual Entrainment (AVE),
Cranio-electro Stimulation (CES) & transcranial DC Stimulation
(tDCS)Dave Siever graduated in 1978 as an engineering technologist
who initially worked to design TMJ Dysfunction related diagnostic
equipment and research facilities. Dave had noted anxiety issues in
many patients suffering with TMJ dysfunction, prompting him to study
biofeedback, which he applied to the patients and then later, Dave
design biofeedback devices. In 1984, Dave designed his first
audio-visual entrainment (AVE) device – the “Digital Audio-visual
Integration Device,” or DAVID1. Through his company, Mind Alive
Inc., Dave has been researching and refining AVE technology,
specifically for use in relaxation, boosting academic performance and
treating anxiety, depression, PMS, ADD, FMS, SAD, pain, cognitive
decline and insomnia. Dave also designs Cranio-Electro Stimulation
(CES) products and is a leading provider of transcranial DC
stimulation (tDCS) and devices. As a result of Dave’s commitment to
research, Mind Alive Inc now owns three patents involving
neurotechnology. Dave continues to conduct research, perform a
quantitative EEG service and designs new products pertaining to
enhanced performance and mental wellness.Post-conference
Workshops:Monday & Tuesday 26-27/08/19> The Absolute Basics: Beginners
EEG Recording and QEEG AnalysisDr. Rivi Sela is the co-founder and CEO
of BetterFly Neurofeedback, an innovative cloud-based neurofeedback
technology that allows clinicians to treat patients both in the clinic
and at the patient’s home. Rivi pioneered the neurofeedback field in
Israel and has trained many neurofeedback clinicians. She founded the
BrainGames-Israel clinics ten years ago, and treated hundreds of
patients suffering from ADHD, epilepsy, autism, anxiety and
depression. Under her supervision, the BrainGames clinics have
provided diagnostic evaluations, QEEG recordings and analyses and
non-drug interventions to patients of all ages, children and adults.
Prior to embarking on her neurofeedback career, Rivi served for many
years as the Chief Technology Director of the Sheba Hospital, the
largest medical centre in Israel, and specialized in developing and
implementing clinical technologies, including hardware and software,
collaborating with leading companies from around the world.Michelle
Aniftos BCN QEEGDis a Clinical Psychologist and Director of a private
mental health practice (Mylne Street Mental Health) in Toowoomba,
Queensland. She has been accredited by Australian Health Practitioner
Regulation Agency and the Australian Psychological Society’s
Clinical College as a Supervisor of provisional and registered
psychologists, and clinical registrars. Michelle is past Convener of
the Australian Neurofeedback & Psychology Interest Group; President
and Fellow of the Applied Neuroscience Society of Australasia; and
Chair of the Biofeedback Certification International Alliance -
Australia. Monday & Tuesday 26-27/08/19> The Use of Neurostimulation
(tDCS, tACS, tRNS, pEMF) and Clinical Neurotherapy in Clinical
PracticeDr. Nicholas Dogris is a licensed health psychologist and
neuroscientist (BCN & QEEGD) at NeuroField Neurotherapy in Santa
Barbara, California. He is the neurorehabilitation director at the
Florida House Experience in Deerfield Beach, Florida which is a
substance abuse and mental health rehabilitation program. He has been
in the electroencephalography (EEG) field for 30 years, beginning in
1987 with P300 research at Humboldt State University. Dr. Dogris
earned his PhD from the California School of Professional Psychology
and holds four advanced degrees. He has worked in the field for 27
years and has experience working with a wide variety of mental health
populations including children, adolescents and adults. Dr. Dogris has
held positions as the Program Chief of Mono County Mental Health,
Orange County Mental Health, Inyo County Mental Health and College
Hospital. He is the co-founder and CEO of NeuroField, Inc which he
co-founded in 2008. He developed the first, synchronized,
neuromodulation and neurofeedback system that utilized normed
referenced data and QEEG analysis for the treatment of multiple
neurological problems. This system, known as NeuroField, combines
pulsed electromagnetic fields (pEMF) and transcranial
alternating/direct current stimulation (tDCS/tACS) with EEG
neurofeedback so as to optimize the functioning of the human brain.
Dr. Dogris has developed over 200 protocols for the NeuroField system
and continues to create new innovations for the Florida House
Experience patients with a specific emphasis on reducing cravings,
reducing symptoms of anxiety and depression and helping to restore
normal sleeping patterns. Dr. Dogris conducts research on tDCS, tACS,
tRNS, pEMF and neurofeedback based modalities.Dr. Tiffany Thompson is
the CEO of Neurofield Neurotherapy, Inc. She works alongside her
husband, Dr. Dogris, as a clinician and educator in the realm of
clinically-applied neurostimulation. Dr. Thompson is a board certified
neurotherapist, licensed psychotherapist, Quantitative EEG Diplomate,
and Registered EEG Technician (a medical credential bestowed by the
American Society of Neurodiagnostic Technicians). Dr Thompson has
worked in neurology clinics, as well as clinical settings. She holds
two Masters degrees (Depth Counseling Psychology; & Communication).
She has a PhD in Psychology with a dissertation on the intersection of
psychodynamic psychology model of the psyche and
electroencephalography. Dr. Thompson has served as the Executive
Director of the Western Association of Biofeedback and Neuroscience,
and worked as a neurodiagnostician in neurology clinics. Dr. Thompson
regularly delivers public and trade organization lectures on Brain
Mapping (Quantitative EEGs), Clinical Quantitative EEGs, Brainwaves
101, neurotherapy, and induced meditative states.
art
727
Views
23/08/2019 Last update